Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about atopic dermatitis
Recent news which mentions atopic dermatitis
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
May 16, 2024
Tickers
JNJ
NEWS
SWAV
Tags
Benzinga
Biotech
Large Cap
From
Benzinga
Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis
April 11, 2022
Tickers
LLY
Tags
Large Cap
Biotech
Benzinga
From
Benzinga
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
April 07, 2022
Tickers
VYNE
Tags
VYNE
Health Care
Movers
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
SNY
News
General
From
Benzinga
ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023
January 21, 2022
Tickers
ASLN
Tags
Briefs
Trading Ideas
Phase 2 Trial
From
Benzinga
FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older
January 18, 2022
Tickers
ABBV
Tags
Guidance
Briefs
Benzinga
From
Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
November 30, 2021
Tickers
HOTH
Tags
Market News
Health Care
Exclusives
From
Benzinga
Connect Biopharma's Mid-Stage Atopic Dermatitis Trial Meets Primary Endpoint
November 19, 2021
Tickers
CNTB
Tags
News
General
CNTB
From
Benzinga
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
September 30, 2021
Tickers
ABBV
Tags
Phase 3
General
News
From
Benzinga
Pfizers' JAK Inhibitor Approved In Japan For Atopic Dermatitis
September 30, 2021
Tickers
PFE
Tags
Market News
Health Care
News
From
Benzinga
Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?
September 27, 2021
Tickers
ASLN
Tags
ASLN
Movers
Health Care
From
Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
Market News
Movers
Health Care
From
Benzinga
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
August 30, 2021
Tickers
PFE
REGN
SNY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
August 30, 2021
Tickers
REGN
SNY
Tags
Health Care
Phase 3 Results
Market News
From
Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
August 16, 2021
Tickers
LLY
Tags
Benzinga
atopic dermatitis
Biotech
From
Benzinga
VYNE Therapeutics Stock Drops On Potential Sale Of Topical Minocycline Franchise
August 12, 2021
Tickers
VYNE
Tags
VYNE
Market News
Contracts
From
Benzinga
FDA Will Not Meet Goal Dates For Pfizer's Xeljanz, Abrocitinib Applications
July 22, 2021
Tickers
PFE
Tags
spondylitis
Briefs
Benzinga
From
Benzinga
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
July 16, 2021
Tickers
ABBV
INCY
LLY
Tags
Market News
ABBV
Health Care
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit